0001752724-21-022505.txt : 20210216
0001752724-21-022505.hdr.sgml : 20210216
20210216090203
ACCESSION NUMBER: 0001752724-21-022505
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201130
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
EFFECTIVENESS DATE: 20210216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Copeland Trust
CENTRAL INDEX KEY: 0001502745
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22483
FILM NUMBER: 21633091
BUSINESS ADDRESS:
STREET 1: 1400 PEOPLES PLAZA
STREET 2: SUITE 104
CITY: NEWARK
STATE: DE
ZIP: 19702
BUSINESS PHONE: 617-399-6935
MAIL ADDRESS:
STREET 1: 1400 PEOPLES PLAZA
STREET 2: SUITE 104
CITY: NEWARK
STATE: DE
ZIP: 19702
FORMER COMPANY:
FORMER CONFORMED NAME: Edgartown Trust
DATE OF NAME CHANGE: 20101004
0001502745
S000030695
Copeland Dividend Growth Fund
C000095114
Copeland Dividend Growth Fund Class A shares
CDGRX
C000109647
Copeland Dividend Growth Fund Class C shares
CDCRX
C000124573
Copeland Dividend Growth Fund Class I shares
CDIVX
0001502745
S000056507
Copeland SMID Cap Dividend Growth Fund
C000178802
Copeland SMID Cap Dividend Growth Fund Class I Shares
CSMDX
C000209896
Copeland SMID Cap Dividend Growth Fund Class A Shares
CSDGX
N-CEN
1
primary_doc.xml
X0303
N-CEN
LIVE
0001502745
XXXXXXXX
811-22483
N-1A
S000056507
C000178802
C000209896
S000030695
C000095114
C000109647
C000124573
Copeland Trust
811-22483
0001502745
5493005MVJ95H6N82870
161 Washington Street
Eight Tower Bridge Suite 1325
Conshohocken
19428
US-PA
US
484-351-3700
Northern Lights Distrbutors
4221 North 203rd Street, Suite 100
Elkhorn
68022
631-470-2600
Relating to its functions as Distributor and principal underwriter of the Funds
Copeland Capital Management, LLC.
161 Washington Street
Conshohocken
19428
484-351-3700
Relating to its functions as Adviser to the Funds.
The Northern Trust Company
50 South LaSalle Street
Chicago
60603
312-630-6000
Relating to its functions as custodian and record keeping
Gemini Fund Services
4221 North 203rd Street, Suite 100
Elkhorn
68022
631-470-2600
Relating to its functions as Administrator, Shareholder Servicing Agent and Accounting and Transfer Agent Records
N
N
N
N-1A
2
Y
Stephen M. Wynne
N/A
N
Ted Rorer
N/A
Y
Thomas A. Leonard
N/A
N
Bruce M. Aronow
N/A
N
Sofia A. Rosala
N/A
161 Washington Street
Suite 1325
Conshohocken
68130
XXXXXX
N
N
N
N
N
N
N
Northern Lights Distributors
8-065857
N/A
N/A
N
N
Tait, Weller & Baker LLP
445
N/A
N
N
N
N
N
N
N
Copeland SMID Cap Dividend Growth Fund
S000056507
549300FTMTF6WH841Y37
N
2
0
0
N/A
N
N
Y
N
N/A
0.00000000
0.00000000
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
Y
N
Copeland Capital Management LLC
801-22483
N/A
N/A
N
Gemini Fund Services, LLC
84-1964
N/A
N
N
N
ICE Data Services
N/A
N
N
The Northern Trust Company
6PTKHDJ8HDUF78PFWH30
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Gemini Fund Services, LLC
84-06083
Filing Number
Y
N
N
Gemini Fund Services, LLC
84-06083
Filing Number
Y
N
N
Robert W. Baird & Co.
8-00497
000008158
549300772UJAHRD6LO53
281.00000000
Raymond James
8-17983
000006694
ZXMJHJK466PBZTM5F379
2463.00000000
Oppenheimer & Co.
8-4077
000000249
N/A
439.00000000
JPMorgan Chase
8-35008
000000079
8I5DZWZKVSZI1NUHU748
368.00000000
Instinet, Inc.
8-23669
000007897
549300MGMN3RKMU8FT57
8825.00000000
Morgan Stanley
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
434.00000000
Liquidnet
8-52461
000103987
213800HSKBBO1GCVRG79
843.00000000
ISI Group
8-49830
000042405
3912008OD2LKOC3EK682
309.00000000
Alliancebernstein
8-30851
000014549
0JK55UGWSWNF3X7KLQ85
593.00000000
Goldman Sachs
8-129
000000361
784F5XWPLTWKTBV3E584
609.00000000
16473.00000000
0
N
14729606.00000000
N
N
N
N
Copeland Risk Managed Dividend Growth Fund
S000030695
549300KVFXT7DVDGME23
N
3
0
0
N/A
N
N
Y
N
N/A
0.00000000
0.00000000
Rule 22d-1 (17 CFR 270.22d-1)
Y
Y
Y
N
Copeland Capital Management LLC
801-22483
N/A
N/A
N
Gemini Fund Services, LLC
84-1964
N/A
N
N
N
ICE Data Services
N/A
N
N
The Northern Trust Company
6PTKHDJ8HDUF78PFWH30
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Gemini Fund Services, LLC
84-06083
Filing Number
Y
N
N
Gemini Fund Services, LLC
84-06083
Filing Number
Y
N
N
Royal Bank of Canada Capital Markets
8-39947
000022698
ES7IP3U3RHIGC71XBU11
9862.00000000
KBC Bank
8-51529
000046709
6B2PBRV1FCJDMR45RZ53
2974.00000000
Goldman Sachs
8-129
000000361
FOR8UP27PHTHYVLBNG30
2739.00000000
Exane, Inc.
8-49569
000041784
6SDWK6FV8H98XAGSYS75
12626.00000000
Instinet, Inc.
8-23669
000007897
549300MGMN3RKMU8FT57
9451.00000000
Raymond James
8-17983
000006694
ZXMJHJK466PBZTM5F379
47892.00000000
William Blair & Co
8-02698
000001252
549300J0P7XYE8BMZ775
2637.00000000
Daiwa Securities
8-12242
000001576
549300OE1DCA4NYQ5H32
9146.00000000
SG Securities
8-68732
000155643
549300X7ULDGXKFTX656
17630.00000000
Berenberg
8-68821
000156757
5493007EG0CYRKKG9L11
2728.00000000
122559.00000000
Goldman Sachs
8-129
000000361
784F5XWPLTWKTBV3E584
57020501.00000000
Morgan Stanley
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
38846717.00000000
JPMorgan Chase
8-35008
000000079
8I5DZWZKVSZI1NUHU748
65199117.00000000
161006336.00000000
N
87487687.00000000
N
N
N
N
true
INTERNAL CONTROL RPT
2
Copeland_N-CEN.txt
COPELAND FUNDS INTERNAL CONTROL LETTER 11.30.2020
REPORT OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
Shareholders and
Board of Trustees
Copeland Trust
Conshohocken, PA
In planning and
performing our audits of
the financial statements
of Copeland Dividend
Growth Fund and
Copeland SMID Cap
Dividend Growth Fund
as of and for the year
ended November 30,
2020, in accordance
with the standards of
the Public Company
Accounting Oversight
Board (United States),
we considered their
internal control over
financial reporting,
including control
activities for
safeguarding securities,
as a basis for designing
our auditing procedures
for the purpose of
expressing our opinion
on the financial
statements and to
comply with the
requirements of Form
N-CEN, but not for the
purpose of expressing
an opinion on the
effectiveness of the
Trust's internal control
over financial reporting.
Accordingly, we
express no such
opinion.
The management of the
Trust is responsible for
establishing and
maintaining effective
internal control over
financial reporting. In
fulfilling this
responsibility, estimates
and judgments by
management are
required to assess the
expected benefits and
related costs of controls.
A company's internal
control over financial
reporting is a process
designed to provide
reasonable assurance
regarding the reliability
of financial reporting
and the preparation of
financial statements for
external purposes in
accordance generally
accepted accounting
principles. A
company's internal
control over financial
reporting includes those
policies and procedures
that (1) pertain to the
maintenance of records
that, in reasonable
detail, accurately and
fairly reflect the
transactions and
dispositions of the
assets of the company;
(2) provide reasonable
assurance that
transactions are
recorded as necessary to
permit preparation of
financial statements in
accordance with
generally accepted
accounting principles,
and that receipts and
expenditures of the
company are being
made only in
accordance with
authorizations of
management and
directors of the
company; and (3)
provide reasonable
assurance regarding
prevention or timely
detection of
unauthorized
acquisition, use or
disposition of a
company's assets that
could have a material
effect on the financial
statements.
Because of inherent
limitations, internal
control over financial
reporting may not
prevent or detect
misstatements. Also,
projections of any
evaluation of
effectiveness to future
periods are subject to
the risk that controls
may become inadequate
because of changes in
conditions, or that the
degree of compliance
with the policies or
procedures may
deteriorate.
A deficiency in internal
control over financial
reporting exists when
the design or operation
of a control does not
allow management or
employees, in the
normal course of
performing their
assigned functions, to
prevent or detect
misstatements on a
timely basis. A
material weakness is a
deficiency, or
combination of
deficiencies, in internal
control over financial
reporting, such that
there is a reasonable
possibility that a
material misstatement
of the company's
annual or interim
financial statements will
not be prevented or
detected on a timely
basis.
Shareholders and
Board of Trustees
Copeland Trust
Page Two
Our consideration of the
Trust's internal control
over financial reporting
was for the limited
purpose described in the
first paragraph and
would not necessarily
disclose all deficiencies
in internal control that
might be material
weaknesses under
standards established by
the Public Company
Accounting Oversight
Board (United States).
However, we noted no
deficiencies in the
Trust's internal control
over financial reporting
and its operation,
including controls for
safeguarding securities,
which we consider to be
material weaknesses, as
defined above, as of
November 30, 2020.
This report is intended
solely for the
information and use of
management,
Shareholders and Board
of Trustees of Copeland
Trust and the Securities
and Exchange
Commission, and is not
intended to be and
should not be used by
anyone other than these
specified parties.
TAIT,
WELLER &
BAKER LLP
Philadelphia,
Pennsylvania
January 29, 2021